Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin. - Wikidata - wikimedia - TriplyDB

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin.

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin.

http://www.wikidata.org/entity/Q33990778

about

Pharmacogenetic studies update in type 2 diabetes mellitus Novel phenotypes of prediabetes?Incretin physiology and pathophysiology from an Asian perspective Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials.Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes Genetics of Type 2 Diabetes and Clinical Utility.Stratified medicine for the use of antidiabetic medication in treatment of type II diabetes and cancer: where do we go from here?Genetics of drug response in type 2 diabetes.Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers.Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis.Effects of artichoke leaf extract supplementation on metabolic parameters in women with metabolic syndrome: Influence of TCF7L2-rs7903146 and FTO-rs9939609 polymorphisms.DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus.A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins.

P2860

Q26739350-DF75CD11-12EA-4D51-B893-7374D21C8B51 Q26747128-7B38DAB1-1D01-48E8-9145-D4C81C060317 Q26784623-4C2F2BAE-D0BC-4845-87C6-6CA88BA97E02 Q30249371-D9CD2D0C-65B1-4E63-AEBA-A88A69BFC956 Q31114603-CCB5D3E5-0CD4-4615-BFE7-237FE05178F7 Q33566802-C5C314B1-80E9-4E6F-A386-C9BE9F4A4211 Q35808509-28D753F7-3BE4-4E0C-9946-78078E86FE79 Q38270699-FBF38903-FC4E-46F6-9A9A-3A7865AE325C Q38480670-44903C72-7E00-4A1D-9171-6334D2A5B422 Q38816602-E3DB0CEC-BAC6-44E7-ACF2-9ED88131A050 Q38831752-5B820704-0FF1-4CFC-A08B-3ADFF617A327 Q47674613-764DAEB4-9FF0-43E3-9D6D-0A35BEB31268 Q48201768-3ACE58B7-8246-4558-A94D-FFDC7BA71F68 Q48229830-7A2918F8-3C8D-4D00-87CC-D86A79D6B4B7 Q51726149-65B7C70D-1322-44A2-91C0-9B499551671B Q53103669-F07CB52C-7D35-42B7-9B3A-63C656C1257A

P2860

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin.

http://www.wikidata.org/entity/Q33990778

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@ast

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@en

type

label

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@ast

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@en

prefLabel

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@ast

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@en

P1433

Q33990778-2BC22CF3-BDEC-450C-BCD3-BD66D90B3667

P1476

Q33990778-9E3FD27C-C5BD-4F73-85D1-3CDDED848490

P2093

Q33990778-0F5A84A5-26D0-4CE5-BC38-DBAC99075183

Q33990778-3EAD1C11-C775-45EF-9A51-67F35BA658F6

Q33990778-81B7E8A4-2D2C-45AB-A0DB-5D9856718E5F

Q33990778-8EE60210-EE83-44DC-A646-4619B1AD45D8

Q33990778-A2CAB425-3F02-4F10-8483-886419C2BF6E

Q33990778-C54180F3-E5A5-4E5F-B24C-7D1B15F8F614

Q33990778-C6D94242-98DA-4F1B-A165-9A66F3154C60

P2860

Q33990778-0385EE0B-B8A8-4B3E-984E-5DF1AD5A07E7

Q33990778-049AB92E-F6E5-4C24-ADA7-0B6484D55C61

Q33990778-0BEF6212-4305-46BA-AECA-AC19B938B764

Q33990778-0CA43F85-B668-475C-9EAD-D6B93EAE9989

Q33990778-1D46CA86-491C-47FB-8248-0C350D0CB022

Q33990778-27584398-2EE8-4AC9-B154-E4ECCDD8BDFE

Q33990778-2D3FE3F4-1565-4F27-A1FE-9D6548A72D49

Q33990778-32F8FDA1-38F8-450B-88EA-040A2357AE45

Q33990778-3E918CAD-1CD0-4540-83C7-908142D59742

Q33990778-4267BD6A-FD1E-4F4D-AA36-EFAB3BA6B915

P2888

Q33990778-9C643C14-9B0A-4518-9340-1A07515C5C97

P304

Q33990778-93A04A01-FCEE-4834-A503-FCD615473F48

P31

Q33990778-EBBECF6F-9AB7-4C5C-A9A0-FE73E9D4DE53

P356

Q33990778-89B40F52-0393-4906-915B-A9E92673E937

P433

Q33990778-75A9429E-3EFE-42CF-8BAD-B117B1B555C7

P478

Q33990778-159BE855-BE31-490C-960B-A1B53E1CD2F0

P577

Q33990778-003514C7-D7C5-4932-9709-6A1842BBA580

P5875

Q33990778-D50DBE3D-5BF6-4C27-8DA1-1CDBE62DF477

P6179

Q33990778-20521DAD-443D-425C-9C44-7C67DE5C290C

P698

Q33990778-B379F448-7D6F-4F96-85E6-A2F755F42255

P932

Q33990778-B96FF54E-FBC2-486F-9F9F-F5AE5547656E

P356

S00125-014-3276-Y

P1433

P1476

Influence of TCF7L2 gene varia ...... idase-4 inhibitor linagliptin.

@en

P2093

Bernhard O Boehm

http://www.w3.org/2001/XMLSchema#string

Carina Ittrich

http://www.w3.org/2001/XMLSchema#string

Hans-Juergen Woerle

http://www.w3.org/2001/XMLSchema#string

Heike Zimdahl

http://www.w3.org/2001/XMLSchema#string

Klaus A Dugi

http://www.w3.org/2001/XMLSchema#string

Michael Mark

http://www.w3.org/2001/XMLSchema#string

Ulrike Graefe-Mody

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets

Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function

dbSNP: the NCBI database of genetic variation

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus

Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes

Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis

P2888

s00125-014-3276-y

P304

1869-1875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00125-014-3276-Y

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262929135

http://www.w3.org/2001/XMLSchema#string

P6179

1013342659

http://www.w3.org/2001/XMLSchema#string

P698

24906949

http://www.w3.org/2001/XMLSchema#string

P932

4119242

http://www.w3.org/2001/XMLSchema#string